US 10695352
Combination therapy for treating malignancies
granted A61KA61K2300/00A61K31/53
Quick answer
US patent 10695352 (Combination therapy for treating malignancies) held by Agios Pharmaceuticals, Inc. expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2300/00, A61K31/53, A61K31/706, A61K31/7068